{
    "2019-07-04": [
        [
            {
                "time": "",
                "original_text": "药明康德(02359.HK)：资本公积储备转增股本，共增发4.19亿股A股及4871.82万H股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "资本公积",
                        "转增股本",
                        "增发",
                        "A股",
                        "H股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业: 注册申请高增长, 审评通过高效率, 国产创新药迎来黄金收获期",
                "features": {
                    "keywords": [
                        "医药生物",
                        "注册申请",
                        "审评通过",
                        "国产创新药",
                        "黄金收获期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}